Individuals genetically predisposed to Alzheimer's may face heightened epilepsy risk, while certain epilepsy types correlate with an increased likelihood of Alzheimer's development.
Read More
The FDA's recent approval of diazepam nasal spray (Valtoco, Neurelis) signifies a breakthrough for epilepsy patients aged 6 and older, offering acute treatment for distinct seizure episodes, including clusters.
Read More
Nocturnal seizures, occurring during sleep, manifest with unusual behavior like sudden awakenings, unexplained urination, and body jerks, posing unique challenges for those affected.
Read More